Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding.
Therapeutic advances in tremor.
The Relationship Between Familial Mediterranean Fever Gene (MEFV) Mutations and Clinical and Radiological Parameters in Multiple Sclerosis Patients.
Targeting the low-hanging fruit of neurodegeneration.
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.
Using conceptual work products of case management to design health IT.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
Loss of branched o-mannosyl glycans in astrocytes accelerates remyelination.
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Porphyrin derivatives as potent and selective blockers of neuronal Kv1 channels.
Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Methods for identifying subject-specific abnormalities in neuroimaging data.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »